Report Detail
Global Rabies Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4652620 |
- 05 December, 2025 |
- Global |
- 88 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Rabies Vaccine market size was valued at US$ 1036 million in 2024 and is forecast to a readjusted size of USD 1350 million by 2031 with a CAGR of 3.9% during review period.
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
This report is a detailed and comprehensive analysis for global Rabies Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Rabies Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Rabies Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Rabies Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Rabies Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Rabies Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Rabies Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Rabies Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
Market segment by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
Major players covered
GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rabies Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rabies Vaccine, with price, sales quantity, revenue, and global market share of Rabies Vaccine from 2020 to 2025.
Chapter 3, the Rabies Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rabies Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Rabies Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rabies Vaccine.
Chapter 14 and 15, to describe Rabies Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Rabies Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Vero Cell Rabies Vaccine
- 1.3.3 BHK
- 1.3.4 Chick Embryo Cell Rabies Vaccine
- 1.3.5 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Rabies Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Pre-exposure Prophylaxis
- 1.4.3 Post-exposure Prophylaxis
- 1.5 Global Rabies Vaccine Market Size & Forecast
- 1.5.1 Global Rabies Vaccine Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Rabies Vaccine Sales Quantity (2020-2031)
- 1.5.3 Global Rabies Vaccine Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 GSK (Novartis)
- 2.1.1 GSK (Novartis) Details
- 2.1.2 GSK (Novartis) Major Business
- 2.1.3 GSK (Novartis) Rabies Vaccine Product and Services
- 2.1.4 GSK (Novartis) Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 GSK (Novartis) Recent Developments/Updates
- 2.2 Sanofi-Pasteur
- 2.2.1 Sanofi-Pasteur Details
- 2.2.2 Sanofi-Pasteur Major Business
- 2.2.3 Sanofi-Pasteur Rabies Vaccine Product and Services
- 2.2.4 Sanofi-Pasteur Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Sanofi-Pasteur Recent Developments/Updates
- 2.3 Chengda
- 2.3.1 Chengda Details
- 2.3.2 Chengda Major Business
- 2.3.3 Chengda Rabies Vaccine Product and Services
- 2.3.4 Chengda Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Chengda Recent Developments/Updates
- 2.4 Yisheng
- 2.4.1 Yisheng Details
- 2.4.2 Yisheng Major Business
- 2.4.3 Yisheng Rabies Vaccine Product and Services
- 2.4.4 Yisheng Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Yisheng Recent Developments/Updates
- 2.5 Prcmise
- 2.5.1 Prcmise Details
- 2.5.2 Prcmise Major Business
- 2.5.3 Prcmise Rabies Vaccine Product and Services
- 2.5.4 Prcmise Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Prcmise Recent Developments/Updates
- 2.6 VACN
- 2.6.1 VACN Details
- 2.6.2 VACN Major Business
- 2.6.3 VACN Rabies Vaccine Product and Services
- 2.6.4 VACN Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 VACN Recent Developments/Updates
- 2.7 Changsheng
- 2.7.1 Changsheng Details
- 2.7.2 Changsheng Major Business
- 2.7.3 Changsheng Rabies Vaccine Product and Services
- 2.7.4 Changsheng Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Changsheng Recent Developments/Updates
- 2.8 BCHT
- 2.8.1 BCHT Details
- 2.8.2 BCHT Major Business
- 2.8.3 BCHT Rabies Vaccine Product and Services
- 2.8.4 BCHT Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 BCHT Recent Developments/Updates
- 2.9 Hissen
- 2.9.1 Hissen Details
- 2.9.2 Hissen Major Business
- 2.9.3 Hissen Rabies Vaccine Product and Services
- 2.9.4 Hissen Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Hissen Recent Developments/Updates
3 Competitive Environment: Rabies Vaccine by Manufacturer
- 3.1 Global Rabies Vaccine Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Rabies Vaccine Revenue by Manufacturer (2020-2025)
- 3.3 Global Rabies Vaccine Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Rabies Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Rabies Vaccine Manufacturer Market Share in 2024
- 3.4.3 Top 6 Rabies Vaccine Manufacturer Market Share in 2024
- 3.5 Rabies Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 Rabies Vaccine Market: Region Footprint
- 3.5.2 Rabies Vaccine Market: Company Product Type Footprint
- 3.5.3 Rabies Vaccine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Rabies Vaccine Market Size by Region
- 4.1.1 Global Rabies Vaccine Sales Quantity by Region (2020-2031)
- 4.1.2 Global Rabies Vaccine Consumption Value by Region (2020-2031)
- 4.1.3 Global Rabies Vaccine Average Price by Region (2020-2031)
- 4.2 North America Rabies Vaccine Consumption Value (2020-2031)
- 4.3 Europe Rabies Vaccine Consumption Value (2020-2031)
- 4.4 Asia-Pacific Rabies Vaccine Consumption Value (2020-2031)
- 4.5 South America Rabies Vaccine Consumption Value (2020-2031)
- 4.6 Middle East & Africa Rabies Vaccine Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Rabies Vaccine Sales Quantity by Type (2020-2031)
- 5.2 Global Rabies Vaccine Consumption Value by Type (2020-2031)
- 5.3 Global Rabies Vaccine Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Rabies Vaccine Sales Quantity by Application (2020-2031)
- 6.2 Global Rabies Vaccine Consumption Value by Application (2020-2031)
- 6.3 Global Rabies Vaccine Average Price by Application (2020-2031)
7 North America
- 7.1 North America Rabies Vaccine Sales Quantity by Type (2020-2031)
- 7.2 North America Rabies Vaccine Sales Quantity by Application (2020-2031)
- 7.3 North America Rabies Vaccine Market Size by Country
- 7.3.1 North America Rabies Vaccine Sales Quantity by Country (2020-2031)
- 7.3.2 North America Rabies Vaccine Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Rabies Vaccine Sales Quantity by Type (2020-2031)
- 8.2 Europe Rabies Vaccine Sales Quantity by Application (2020-2031)
- 8.3 Europe Rabies Vaccine Market Size by Country
- 8.3.1 Europe Rabies Vaccine Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Rabies Vaccine Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Rabies Vaccine Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Rabies Vaccine Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Rabies Vaccine Market Size by Region
- 9.3.1 Asia-Pacific Rabies Vaccine Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Rabies Vaccine Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Rabies Vaccine Sales Quantity by Type (2020-2031)
- 10.2 South America Rabies Vaccine Sales Quantity by Application (2020-2031)
- 10.3 South America Rabies Vaccine Market Size by Country
- 10.3.1 South America Rabies Vaccine Sales Quantity by Country (2020-2031)
- 10.3.2 South America Rabies Vaccine Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Rabies Vaccine Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Rabies Vaccine Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Rabies Vaccine Market Size by Country
- 11.3.1 Middle East & Africa Rabies Vaccine Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Rabies Vaccine Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Rabies Vaccine Market Drivers
- 12.2 Rabies Vaccine Market Restraints
- 12.3 Rabies Vaccine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Rabies Vaccine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Rabies Vaccine
- 13.3 Rabies Vaccine Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Rabies Vaccine Typical Distributors
- 14.3 Rabies Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Rabies Vaccine. Industry analysis & Market Report on Rabies Vaccine is a syndicated market report, published as Global Rabies Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Rabies Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
